Design, Synthesis, SAR and Molecular Modeling Studies of Novel Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives as Highly Potent Antimicrobial Agents. 2018

Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
Department of Polymer Engineering, Faculty of Technology, Karabuk University, 78050, Karabuk, Turkey.

In this study, a novel series of phenyl substituted imidazo[2,1-b][1,3,4]thiadiazole derivatives were synthesized, characterized and explored for antibacterial activity against Gram-negative Escherichia coli, Gram-positive Staphylococcus aureus and Bacillus subtilis and antifungal activity against Candida albicans. Most of the synthesized compounds exhibited remarkable antimicrobial activities, some of which being ten times more potent than positive controls. The most promising compound showed excellent activity with MIC value of 0.03 μg/ml against both S. aureus and B. subtilis (MIC values of positive compound Chloramphenicol are 0.4 μg/ml and 0.85 μg/ml, respectively). Furthermore, structure-activity relationship was also investigated with the help of computational tools. Some physicochemical and ADME properties of the compounds were calculated too. The combination of electronic structure calculations performed at PM6 level and molecular docking simulations using Glide extra-precision mode showed that the hydrophobic nature of keto aryl ring with no electron withdrawing substituents at para position enhances activity while electron-donating substituents at the second aryl ring is detrimental to activity.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
July 2009, European journal of medicinal chemistry,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
July 2016, Acta poloniae pharmaceutica,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
March 2023, Chemistry & biodiversity,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
April 2019, European journal of medicinal chemistry,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
September 2016, Acta poloniae pharmaceutica,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
October 2014, Bioorganic & medicinal chemistry letters,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
January 2024, Medicinal chemistry (Shariqah (United Arab Emirates)),
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
April 2024, Chemistry & biodiversity,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
June 2011, European journal of medicinal chemistry,
Hakan Tahtaci, and Hatice Karacık, and Abdulilah Ece, and Mustafa Er, and Mine Gül Şeker
January 2015, Acta poloniae pharmaceutica,
Copied contents to your clipboard!